Back
EHRA Premium Access

Evolving changes of outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study.

Session: New on atrial fibrillation
Topic: Epidemiology, Prognosis, Outcome
Speaker: Professor L. Fauchier (Tours, FR)
Event: EHRA 2022

Congress Presentation

About the speaker

Professor Laurent Fauchier

University Hospital of Tours, Tours (France)
14 presentations
1 follower

4 more presentations in this session

The 3S-AF scheme, rather than the 4S-AF scheme, predicts progression in patients with paroxysmal atrial fibrillation: data from RACE V study

Speaker: Doctor V. Artola (Groningen, NL)

Access
Abstract
Slides
Video
Thumbnail

Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database

Speaker: Doctor A. Fawzy (Liverpool, GB)

Access
Abstract
Slides
Video
Thumbnail

Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population

Speaker: Doctor A. Fawzy (Liverpool, GB)

Access
Abstract
Slides
Video
Thumbnail

Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project

Speaker: Doctor A. Fawzy (Liverpool, GB)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

New on atrial fibrillation

Speakers: Professor L. Fauchier, Doctor V. Artola, Doctor A. Fawzy, Doctor A. Fawzy, Doctor A. Fawzy
Access
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb